OncoLens Resources

1
2
3
4
5

Jan 26, 2023 | CME

Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors

Jan 19, 2023 | Blog

OncoLens Empowers Molecular Tumor Boards

Dec 13, 2022 | Blog

OncoLens Streamlines NAPRC Accreditation through Advanced Patient Tracking and Analytics Reporting

Project ECHO

Dec 06, 2022 | News

ACCC and Boston University Present the Project ECHO® Eight-Part Webinar Series, Powered by OncoLens

Nov 28, 2022 | CME

Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors

Oct 25, 2022 | CME

Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors

women-led digital health

Sep 22, 2022 | News

Women-Led Digital Health: The Women Behind Digital Health Innovations and the Journey to Success

Sep 20, 2022 | CME

Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors

Aug 26, 2022 | CME

Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies

Jul 19, 2022 | News

MIB Agents Selects OncoLens to Support and Expand its TURBO Program Globally

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer: Program Highlights

May 12, 2022 | CME

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer

oncolens video

Mar 15, 2022 | Education

Quality Improvement Program Webinar—Breast and Ovarian Cancer Biomarker Testing

1
2
3
4
5

© 2017- OncoLens | All Rights Reserved